Fever is a fundamental response to infection and a hallmark of inflammatory disease, which has been conserved and shaped through millions of years of natural selection. Although fever is able to stimulate both innate and adaptive immune responses, the very nature of all the molecular thermosensors, the timing and the detailed mechanisms translating a physical trigger into a fundamental biological response are incompletely understood. Here we discuss the consequence of hyperthermic stress in dendritic cells (DCs), and how the sole physical input is sensed as an alert stimulus triggering a complex transition in a very narrow temporal window.
| INTRODUCTION
The immune system of vertebrates is organized to respond either to pathogens or to noxae that cause damage or trauma. In both cases, the organism needs to activate a complex system composed of warning signals, cellular receptors to respond, signalling pathways and outputs in the form of physiological responses. Endogenous signals that alert the immune system on cell and tissue damage are called "alarmins," whereas pathogen-associated molecular patterns (PAMPs) flag the presence of intruding pathogens. Together, alarmins and PAMPs constitute the larger family of damage-associated molecular patterns, or DAMPs. The insulin-like growth factor (IGF) system is essential for growth and development, and it has been implicated in several diseases. 8 IGF activity is precisely regulated by a family of six high-affinity IGF binding proteins (IGFBPs). 9 Moreover, IGFBPs bind non-IGF ligands in the extracellular space, cell membrane, cytoplasm and nucleus, thereby modulating cell proliferation, survival and migration in an IGF-independent manner. 10 Fever, a hallmark of infection and inflammation, is comprised of physiological and neurological circuitries that have been conserved in warm and cold-blooded vertebrates for over 600 million years of evolution. Significantly, fever represents a fundamental systemic response which stems from the recognition of PAMPs by PRRs, determining the production of cytokines, among which IL-6 is the most important mediator for fever induction and orchestrating lymphocyte trafficking to lymphoid organs.
In this review, we have highlighted new findings related to the effect of fever-range hyperthermia on the immune system, in particular DC activation and metabolic reprogramming, monocyte and T cell chemotaxis, and neutrophil activation. A novel role for insulinlike growth factor binding protein 6 (IGFBP-6) is also discussed in this hyperthermia-induced rewiring of the immune system. Implications for the inflammatory response in autoimmune diseases and cancer are also presented.
| HYPERTHERMIA INDUCE S SPECIFIC GENETIC AND METABOLIC REPROGRAMMING OF DEND RITIC CELLS
Febrile temperatures (ie, ranging from 38-41°C; DT~1-4°C above baseline) boost the effectiveness of the immune response during infections by stimulating both the innate and adaptive arms of the immune system. 11 Indeed, hyperthermia elicits neutrophil functions, DC maturation and DC ability to stimulate T cells, enhance T cell trafficking through lymph nodes and effector T cell differentiation.
AS fever is known to confer a survival advantage by warding off attack by invading pathogens, it is crucial to understand in greater details how it activates sensors, transducing pathways and effector mechanisms.
A wealth of data on the role of metabolic pathways controlling immune cell function have shed new light on both the innate and adaptive immune response, and led to the discovery of "immunometabolism" as an important area of research. [12] [13] [14] Notably, metabolic processes (eg, glycolysis, the Krebs cycle and fatty acid metabolism) have all been shown to have highly specific effects on DCs function 15, 16 and, most importantly, alterations of either one of these metabolic pathways have been shown to dramatically alter the functioning of these cells in ways not simply linked to energy production or general biosynthesis. 17 Recently, we explored how a short-term mild hyperthermal activation of monocyte-derived dendritic cells (MoDCs) intertwined with changes in the metabolic phenotype. 18 In this context, we focused mainly on the mitochondrial respiratory and oxidative phosphorylation (OxPhos) activity given their pivotal role in the cell bioenergetics. In summary, we found that: (i) fever-like hyperthermia This clearly points to a cell-specific sensitivity of the mitochondrial activity to the thermal stress and suggests that metabolic pathways under thermal control are of pivotal importance in DCs physiology.
Our priority in fact has been to study DCs-specific response to hyperthermia as a mean to better understand fundamental mechanisms controlling immunity.
Importantly, re-conditioning of the 39°C-treated MoDCs to normothermia did not appreciably recover the mitochondria-related activities showing the irreversible nature of this observation. Again this fact suggests that response to fever in DCs is a fundamental and solid process which rapidly activates complex and important pathways in DCs, not easily inhibited after activation.
As activation of immune-competent cells is also known to be accompanied with changes in the cell secretome, 20 tumours. 31 Moreover, IGF-II is involved in cardiovascular disease, likely because it has been shown to influence the size of atherosclerotic lesions. 33 Here we briefly review the main IGFBP-6 categories of actions:
IGF-I and IGF-II dependent, as well as IGF independent functions. F I G U R E 1 Effect of mild hyperthermic stress on dendritic cells. The picture shows schematically the main results of a study 18 carried out on cultured human monocyte-derived dendritic cells (MoDCs) exposed for 3 h from 37 to 39°C. The major outcomes, observed in hyperthermic MoDC appear to involve the mitochondrial oxidative metabolism and consisted in decreased activity of the mitochondrial respiratory chain and consequent oxidative phosphorylation (OxPhos), enhanced production of reactive nitrogen and oxygen species (RONS) and overload of intramitochondrial (mt) Ca 2+ ions. This was accompanied with increased glycolysis, suggesting metabolic rewiring, and release of proinflammatory cytokines. All the above reported effects were re-capitulated in normothermic MoDCs exposed to the conditioned medium of the 39°C-treated cells thus suggesting the involvement of secretome-contained factors. On the basis of results of a transcriptome study performed on the same cells under identical hyperthermic conditioning, 21 HSP70 and IGFBP-6 are indicated as putative candidates acting via an autocrine mechanism. The shown protein structures of IGFBP-6 and HSP70 were taken from the RCSB-protein data bank (www.rcsb.org/)
| IGF-I-dependent actions of IGFBP-6
Growth hormone (GH) is the major factor stimulating IGF-I biosynthesis and release, and IGF-I mediates many, but not all, of its activities. 25, 34 The post-natal growth of bone and muscles depends on pre-and post-pubertal levels of IGF-I. 35 IGFBP-3 appears to be the main IGFBP regulating the availability of IGF-I systematically, as most of the IGF-I and IGF-II molecules in serum are found in a 150-kDa ternary complex formed by an IGF, IGFBP-3 and a glycoprotein known as the acid labile subunit (ALS), all synthesized by the liver. 36 Not only IGF-I has endocrine activities, but also autocrine/paracrine ones involved in local growth and response to inflammation.
37
Human IGFBP-6 is found predominantly in cerebrospinal fluid (CSF) and serum 38 ; however, its physiological significance in regard of IGF-I at systemic and local levels remains to be elucidated. 39 Indeed, most studies have failed to show IGF-I inhibition by IGFBP-6. 
| IGF-II-dependent actions of IGFBP-6
IGF-II has been implicated in mitosis, growth and organ development by paracrine and endocrine pathways in cell culture studies and animal models. 9, 37 The main function of IGFBP-6 is inhibiting IGF-II mediated actions concerning cell proliferation, differentiation, migration and survival in many cell lines. 40, 41 In consequence of its inhibitory effect on IGF-II, IGFBP-6 has been shown to inhibit the growth and survival of numerous adult and pediatric tumors.
| IGF-independent actions of IGFBP-6
IGFBP-6 is capable, however, of actions independent of IGF-II, including regulation of proliferation, apoptosis, angiogenesis and cell migration. 10, 42 For example, IGFBP-6 was shown to be effective at attenuating the IGF-II-mediated increase in cell contractility of fibroblasts obtained from Dupuytren's disease (DD) patients, while it inhibited DD fibroblast proliferation through mechanisms that are independent of IGF-II sequestration. binds Ku80, that is part of Ku complex involved in the non-homologous end joining repair, in the cytosol, whereas binds to histone H2Br, which maintains the structural integrity of DNA, in the nucleus. 52 Overall, these interactions could be part of a mechanism by which IGFBP-6 regulates apoptosis. Moreover, it could be implicated in other anti-tumoural effects of IGFBP-6, such as senescence. 53, 54 The specific impact of IGFBP-6 on cell metabolism largely relies on its Intriguingly, one of the recognized IGFBP-6 receptor is prohibitin-2 (PBH2). 57, 58 Although PBH2 is located as a single transmembrane helix spanning protein in the cell membrane, the majority of PBH2 is located in a ring-shaped oligomer in the inner mitochondrial membrane where it functions as a crucial mitophagy receptor. 57 To notice, intracellular binding partners for IGFBP-6 have been identified supporting alternative modalities of action thereof. 10 However, the possible interplay between IGFBP-6 and the mitochondrial PBH2 has not yet been investigated.
Intracellular and intranuclear actions of IGFBP-6 are depicted in Figure 3 .
Moreover, more recently other functions of IGFBP-6 related to the immune system have been discovered (Figure 2 ), as we found that IGFBP-6 in vitro acts as a chemoattractant towards neutrophils, monocytes and T cells, but clearly not B cells. 21, 23 As hyperthermia could induce an increased expression of IGFBP- As we have outlined above, the role of IGFBP-6 in cancer is complex and stems from its primary role as a modulator of IGF-II bioavailability and hence as a negative regulator of cancer cell growth. Indeed, it has been considered a tumour suppressor gene.
On the other hand, IGFBP-6 inhibits angiogenesis and induces apoptosis of cancer cells in an IGF-independent manner. 25 Moreover, IGFBP-6 promotes cancer cell migration (see below).
| CE LL MIGRATION AND CH EMOTAXIS IN TUMOUR MICROENVIRONMENT
The tumour microenvironment (TME) plays a fundamental role in tumour cells' acquirement of cancer hallmarks, thus being involved in cancer formation but also in its progressive and invasive phases. 62, 63 Many cellular components are part of the TME, including fibroblasts, 
| IGFBP-N EW ROLE IN THE INFLAMMATORY RESPONSE AN D INFLAMMATORY DISORDERS
Inflammation and innate immunity are complex phenomenon that are apparently redundant but that may be evolutionarily driven to comply with encounters with diverse damaging and infectious agents. 72 These defensive responses may be eventually subverted in cancer and autoimmune diseases by a wealth of mechanisms, 73 including macrophage and neutrophil plasticity, and loss of immunological tolerance mediated by DCs. 74 Neutrophils are the main cell type involved in the acute inflammatory response. Upon bacterial product release or cytokine production, these cells are primed in the circulation, are attracted into the inflamed tissue where they exert their main defence actions by phagocytosis, ROS production and release of the their granule content. 75, 76 While neutrophil elastase (NE) and myeloperoxidase (MPO)
are stored in primary granules, tertiary granules are enriched with metalloproteases (MMPs), in particular MMP-9. 77 At the mucosal level, this multi-step process leads to migration across the endothelium, the extracellular matrix and the epithelium because of a chemoattractant gradient. 78 We recently investigated whether IGFBP-6 could have any effect on neutrophils' functions as diverse ROS production, degranulation and chemotaxis. 23 180 AE 29% of control, P < .05), with a behaviour similar to SDF-1.
Concentrations of IGFBP-6 lower than 4 nmol/L had no chemotactic activity for T cells. The specificity of the chemotactic effect was shown by the preincubation of IGFBP-6 with an anti-IGFBP-6 antibody that abolished its chemotactic activity.
Rheumatoid arthritis (RA) is a chronic inflammatory disorder, where pannus development and cartilage and bone damage at the joint level recall tumour development and invasion. In a recent study, 22 we have shown that IGFBP-6 serum levels are higher in RA than in healthy controls and patients with osteoarthritis (OA) Such a transition occurs in a narrow temporal window and is accompanied by a significant change in the metabolic reprogramming which therefore is a very early event in the immune response functioning.
Finally, IGFBP-6 seems to play an important role in the control of cell-specific immunologic adaptation following hyperthermia. In vivo experiments are warranted to fully explore the role of IGFBP-6 in pathology and to discover how we might exploit its functions in diagnosis and therapy.
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